RLX | Ticker Profile - Titan Protect

RLX

RLX Technology Inc.

Consumer Defensive · Tobacco · NYQ

$2.00

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.4B

Total market value of the company

Trailing P/E

18.00

Reasonably valued

Forward P/E

11.87

Based on estimated future earnings — lower means cheaper

Rev Growth

+107.4%

Year-over-year revenue change

Profit Margin

22.5%

How much profit the company keeps from each dollar of revenue

ROE

6.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$3.20

+60% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 5 analysts covering this stock

About RLX Technology Inc.

RLX Technology Inc., through its subsidiaries, develops, manufactures, and sells e-vapor products in the People's Republic of China and internationally. It offers rechargeable e-vapor products under the Qingyu, Phantom, Phantom Pro, Zeus, Leili, and Daqian names; and disposable e-vapor products under the Feiliu and Feiliu Mega names. The company also provides closed-system rechargeable products, open-system products, closed-system disposable products, and modern oral products. It sells its products through local channels, third-party distribution channels, and distribution channels co-managed with third parties, as well as online and offline end users. The company was founded in 2018 and is headquartered in Shenzhen, the People's Republic of China.

https://ir.relxtech.com

Country: China Employees: 897 Industry: Tobacco

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.286

Positive but modest risk-adjusted returns

Kelly Fraction

-0.1003

No positive edge detected — the data suggests staying out

Calmar Ratio

0.113

Drawdown risk outweighs the returns — higher risk profile

Annual Return

3.7%

Historical annualised return based on price data

Max Drawdown

-32.5%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.15

Moves slightly more than the broader market

52W High

$2.84

30% below the year high

52W Low

$1.97

2% above the year low

Avg Volume

2,431,350

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

1.0%

Low short interest — limited bearish positioning

Div Yield

505.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$0.11

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

1.32

Meaningful debt load — monitor closely

Current Ratio

8.53

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

7.67

Like current ratio but excludes inventory — stricter test

Gross Margin

33.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

16.6%

Profit from core operations before interest and tax

Free Cash Flow

$-280,764,512

Negative — the business is spending more than it generates

Revenue (TTM)

$4.4B

Total revenue over the last 12 months

Net Income

$984M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$3.58

Target Median

$3.20

Target Low

$2.33

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go